MEDIA RELEASE
Matū Iramoe today announced a 3% increase in share price since November 2021, reflecting the holding value the deep tech venture capital fund has in its 13 portfolio companies.
The announcement comes as the fund opens the doors for a second retail investor raise on Catalist, scheduled to run until 4 April.
Having raised close to $580,000 from their IPO in November 2021, Matū is now seeking to raise up to $500,000 to further invest in Aotearoa New Zealand’s globally scalable, IP-rich, science and deep tech innovations.
Ken Erskine, a Matū Iramoe Director, says the retail raise offers a unique opportunity for Kiwis to buy into the rapidly growing deep tech sector.
“While we can raise capital from wholesale investors, we want to provide an opportunity for all of Aotearoa New Zealand to join us on the journey,” he says.
“Raising through Catalist enables retail investors to participate, which means the vast majority of New Zealanders are eligible to invest.”
Matū’s latest investment, RosterLab, increases the Group’s portfolio to 13 companies who operate in the bio-tech, agri-tech, robotics, and medi-tech sectors, including Mekonos, Alimetry, PowerOn, and Ligar.
RosterLab is a software company that offers an automatic rostering platform to a variety of high-intensity sectors, including healthcare providers, is the latest addition to Matū’s diverse portfolio.
Matū has deployed $4.11 million capital since 2019, delivering an unrealised return of over 87%.
Erskine says prospects for further appreciation in existing investments remains strong and the fund has an extensive pipeline of scientific and deep tech innovations to place capital investment into.
“Aotearoa New Zealand has a highly productive and creative scientific, engineering and technology community. Through our unique networks, relationships, and access across New Zealand’s sources of science, we review over 250 investment opportunities each year.
“We choose to invest in those with verified ideas and defendable intellectual property that offer significant global opportunity, and to which Matū can make a material difference,” Erskine says.
Matū Iramoe’s retail raise is now live on Catalist at www.matu.co.nz/catalist and is available to retail investors and wholesale investors.
About Matū Iramoe and Matū Group: Matū Group operates early-stage venture capital funds with a proven track record of successfully investing in and supporting innovative, IP-rich science, engineering and technology start-ups with disruptive global commercial potential that will make a positive impact on society. Matū Iramoe is an entity of the Matū Group that will function as an investment vehicle, primarily raising capital by way of issues of ordinary shares to invest in a diverse portfolio of science and deep-tech start-up companies.
About Catalist: Catalist is New Zealand’s only licensed stock exchange designed for small and medium-sized businesses. Investors can trade shares, debt securities and other financial products, while businesses can raise new capital. Catalist, which is regulated by the Financial Markets Authority, offers a public market, accessible to retail investors, private markets, for private market trading and capital raising, and bespoke markets, where companies can invite new investors to their private markets.Rather than a continuous trading stock exchange, Catalist uses regular auctions to better-suit smaller business listings.
Investors are invited to attend a live investment webinar with the Matū team on 28 March at 12pm on Catalist’s Facebook page https://fb.me/e/4cyQb7H75
The information contained in this press release does not constitute financial advice or a recommendation of any financial product and should not be relied upon as such. You should always seek professional advice from a licensed advisor.
